AGIO

#1987
Agios Pharmaceuticals, Inc.
33.3000 USD
+0.45%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
33.3000
33.3000
Rango anual
22.2400
45.9900
Cambio diario
+0.45%
Variación mensual
+20.17%
Variación en los últimos 6 meses
-23.25%
Cambio anual
-23.25%
Cierres anteriores
33.1500
Abrir
33.3000
Bid
Ask
Mínimo
33.3000
High
33.3000
Volumen
141
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 1.9511 B
  • Employee 540
  • Founded 2008
  • CEO N/A
  • Website www.agios.com
  • Headquarter Delaware, United States
  • FIGI BBG000QY4ZD0
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.82
Relación precio/flujo de caja
29.21

Agios Pharmaceuticals Inc

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

Noticias